3 AI Chip Stocks to Buy in November After the October Sell-Off

The article argues that Nvidia, Broadcom and Micron could benefit from stronger AI-related demand in 2027 after October declines of more than 10% for Nvidia, 5% for Broadcom and around 20% for Micron. Nvidia cited roughly $1.3 trillion in planned 2027 spending by five hyperscalers, up from nearly $800 billion in 2026, and expects 70% growth; Broadcom expects to double AI semiconductor revenue in 2027, while Micron management said memory-market conditions may be worse in 2027 and 2028 than in 2026. The author describes the stocks as inexpensive against forward earnings—about 13x for Nvidia, 17x for Broadcom and under 5x for Micron—and predicts a rally, but that is the author's view rather than a reported market reaction.

Analysis

The key exposure is not simply “AI growth,” but how capex converts into realized shipments and durable earnings. Hyperscaler budgets are an upstream signal, not proof of utilization, deployment timing, or returns on invested capital; order lead times can pull demand forward and leave a digestion air pocket if projects slip. That makes the three stocks correlated to one capex factor, not a diversified basket.

The relative economics differ. Custom accelerators can take share from Nvidia within workloads while still expanding total compute demand—supportive for Broadcom, but a competitive and pricing risk for Nvidia. Micron has the most operating leverage to tight memory supply, but also the most classic cycle risk: low forward P/E can reflect peak earnings estimates, and elevated prices can incentivize supply additions or demand substitution. Treat management outlook and forward multiples as hypotheses to verify, not settled facts.

Near term, a post-selloff rebound is plausible but November timing is a weak catalyst absent estimate revisions or confirmed spending. Over 1–3 months, track hyperscaler capex guidance, accelerator delivery schedules, and memory contract pricing/supply. Over 6–18 months, the central risk is capex digestion plus supply response. The bullish thesis weakens if hyperscalers defer projects, Nvidia/Broadcom guidance fails to convert into shipments, or memory pricing rolls over. The contrarian point: headline growth may be widely recognized; the market may be discounting execution and cycle risk rather than overlooking 2027 demand.

Key Decisions for Investors

• Do not buy the three names as an undifferentiated “cheap AI” basket. If adding exposure, scale in around company updates and require evidence of order-to-revenue conversion; avoid treating forward P/E as a floor.
• Relative-value watch: consider a beta-adjusted long AVGO / short MU expression only if custom-accelerator demand remains firm while memory contract-price momentum or supply discipline deteriorates. This targets differing earnings-cycle risk, not a claim that memory demand is already weakening; cap risk because both remain exposed to hyperscaler capex.
• Keep NVDA as a conditional core exposure rather than assuming custom silicon is purely incremental. Reassess on evidence of accelerator share loss, delivery slippage, or weaker forward guidance; sustained shipment and estimate growth would falsify the bearish substitution case.
• Key dashboard for the next 1–3 months: hyperscaler capex revisions and project timing, company shipment/backlog conversion, and memory pricing plus announced capacity additions. If these remain supportive, revisit the broader long thesis; if capex is deferred or memory prices turn down, reduce cyclical exposure.